Today: 30 April 2026
Browse Category

Stock Market 26 January 2026

American Express stock price edges up after hours as AXP heads into Fed decision and earnings

American Express stock price edges up after hours as AXP heads into Fed decision and earnings

American Express shares rose 0.5% to $363.33 in after-hours trading Monday, ahead of its Friday earnings report. The S&P 500 closed up 0.5% and the Dow gained 0.6% as investors braced for Wednesday’s Federal Reserve decision and a wave of corporate results. Visa, Mastercard, and Capital One also advanced late. Analysts expect AmEx to report $3.55 per share for the quarter.
26 January 2026
···
Cisco stock jumps on Evercore upgrade as Cisco rolls out new 360 Partner Program

Cisco stock jumps on Evercore upgrade as Cisco rolls out new 360 Partner Program

Cisco shares rose 3.3% to $77.02 in after-hours trading Monday after Evercore ISI upgraded the stock and raised its price target to $100, citing AI demand and an enterprise network upgrade cycle. Cisco also launched its new “Cisco 360” partner program targeting AI. Arista Networks and Hewlett Packard Enterprise shares also advanced during the session. Cisco’s next earnings report is scheduled for Feb. 11.
26 January 2026
··
Palo Alto Networks stock climbs after the bell as Fed decision nears — what traders watch next

Palo Alto Networks stock climbs after the bell as Fed decision nears — what traders watch next

Palo Alto Networks shares rose 2.2% to $184.19 in late Monday trading, with about 5.3 million shares changing hands. CrowdStrike, Fortinet, and Zscaler also advanced ahead of the Federal Reserve’s rate decision Wednesday. Nike said it is investigating a possible data breach after a ransomware group claimed to have leaked company data. Investors are watching for big-tech earnings and Fed policy signals this week.
26 January 2026
······
Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol shares rose 3% to close at $155.53 on Monday, outpacing the S&P 500 ahead of its fourth-quarter earnings release set for Wednesday. The move follows the company’s recent $4.1 billion acquisition of CommScope’s Connectivity and Cable Solutions business. Investors are also watching for the Federal Reserve’s rate decision on Jan. 28.
26 January 2026
······
Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks shares rose 5.4% to $143.70 Monday, nearing last week’s high amid renewed tech buying ahead of major earnings and a Federal Reserve decision. Options activity and anticipation of Arista’s Feb. 12 earnings report drove trading. Investors are watching for 2026 demand signals and updates on AI-related orders. U.S. stocks edged higher as traders weighed megacap and AI names.
26 January 2026
···
Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play

Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play

Marvell Technology shares rose 1.5% to $81.44 Monday, outpacing chip sector peers during a volatile session. The move followed recent acquisitions of XConn Technologies for $540 million and Celestial AI for $3.25 billion, both aimed at boosting data-center and AI infrastructure. About 9.2 million shares traded by mid-afternoon. Investors focused on upcoming Fed policy and major tech earnings.
26 January 2026
····
Central Puerto (CEPU) stock rises in New York — what investors are watching ahead of the Fed

Central Puerto (CEPU) stock rises in New York — what investors are watching ahead of the Fed

Central Puerto’s U.S.-listed shares rose 2.8% to $16.91 Monday, after swinging between $16.23 and $17.95 with 731,000 shares traded. Argentina-linked assets gained, with the Global X MSCI Argentina ETF up 1.5%. Investors tracked Federal Reserve signals and recent Central Puerto filings, including a $300 million IFC financing and a 30-year hydroelectric concession.
26 January 2026
···
1 … 377 378 379 380 381 … 1,402

Stock Market Today

  • Standard Chartered Shares Surge on Record Q1: A FTSE 100 Banking Opportunity?
    April 30, 2026, 8:53 AM EDT. Standard Chartered (LSE: STAN) shares jumped 4% following a record first quarter, contrasting with losses seen in Lloyds Banking Group's stock despite better-than-expected results. CEO Bill Winters highlighted strong growth in Wealth Solutions and Global Banking, with full-year 2026 guidance maintained at 5%-7% operating income growth. The bank posted a 9% rise in operating profit to $5.9 billion and a 17% increase in pre-tax profit to $2.5 billion, despite $296 million in impairment charges linked to Middle East conflicts. Shares trade at a price-to-earnings ratio of 11, with a modest 2.6% dividend yield expected in 2026. Investors weigh the risks of emerging market exposure against steady profits and disciplined risk management.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop